Altre lingue Porton Pharma Solutions Ltd.

Azioni

300363

CNE100001S57

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 17/04/2024			Variaz. 5gg	Var. 1 gen.
16,71 ^CNY	+3,47%		-5,75%	-33,56%

2023	Porton Pharma Solutions Ltd. (SZSE:300363) annuncia un riacquisto di azioni per un valore di 30 milioni di CNY.	CI
2023	Porton Pharma Solutions Ltd. Riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	09/04
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.	09/04
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	03/04
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	03/01
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	27/10/23
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	27/10/23
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.	15/09/23
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023	28/04/23
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/04/23
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022	18/04/23
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders	03/04/23
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022	27/03/23
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/03/23
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility	20/01/23
China’s Porton to set up biotech park in Slovenia’s Menges	10/01/23
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.	22/11/22
Porton Pharma Solutions Ltd.'s Equity Buyback announced on August 4, 2022, has closed with 2,022,344 shares, representing 0.37% for CNY 100 million.	21/11/22
Shanghai Feiteng Pharmaceutical Technology Co., Ltd. announced that it has received CNY 60 million in funding from Porton Pharma Solutions Ltd.	27/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Porton Pharma Solutions Ltd.

Azioni

300363

CNE100001S57

Altre lingue

Filtri